BIB ProShares Trust - ProShares Ultra Nasdaq Biotechnology
2,179
$58.49
$0.9353
(1.63%)
| Watchers | 2,179 |
| 52-Wk Low | $40.10 |
| 52-Wk High | $62.45 |
| Volume | 17,004.00 |
| 52-Wk High | $62.45 |
| 52-Wk Low | $40.10 |
Palumbo Wealth Management LLC Makes New $228,000 Investment in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB)Ticker Report • about 2 months ago
Palumbo Wealth Management LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB - Free Report) in the fourth quarter, according to its most recent disclosure with...
Share to Feed
This is a signal that BIB's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
For the last three days, A.I.dvisor has detected that BIB's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 55,700...
This indicator may be signaling BIB's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This is a Bullish indicator signaling BIB's price could rise from here. Traders may explore going long the stock or buying call options...
For the last three days, A.I.dvisor has detected that BIB's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This is a signal that BIB's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Capital Investment Advisors LLC reduced its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB Free Report) by 4.4% in the 4th quarter, according to the company in its most recent...